| Literature DB >> 35946834 |
Paulina S Marell1, Robert A Vierkant2, Janet E Olson2, Joerg Herrmann3, Nicole Larson2, Nathan K LeBrasseur4, Stacy D D'Andre5, Andrea L Cheville4, Toure Barksdale4, Charles L Loprinzi5, Fergus Couch6, Kathryn J Ruddy5.
Abstract
Physical activity (PA) is associated with improvement in breast cancer treatment-related symptoms and survival, yet most breast cancer survivors do not meet national PA guidelines. This study aimed to identify characteristics of participants that were associated with an increased likelihood of meeting PA guidelines. Adults with breast cancer seen at Mayo Clinic (Rochester, MN) were surveyed regarding their PA participation, and those who self-reported at least 150 minutes of moderate and/or strenuous aerobic PA weekly on average were considered to be "meeting guidelines". Three thousand participants returned PA data. Younger age, completion of the survey 7-12 years after diagnosis, absence of recurrence, no bilateral mastectomy, absence of metastatic disease, and lower BMI at the time of survey completion were associated with PA participation (P < .05 in univariate and multivariate analyses). Findings were similar when a threshold of 90 minutes was applied. These results may inform the development of targeted PA-facilitating interventions.Entities:
Keywords: breast neoplasms; cancer survivors; exercise; health behavior
Mesh:
Year: 2022 PMID: 35946834 PMCID: PMC9526500 DOI: 10.1093/oncolo/oyac159
Source DB: PubMed Journal: Oncologist ISSN: 1083-7159 Impact factor: 5.837
Univariate associations of participant and tumor characteristics with meeting guidelines of at least 150 minutes of moderate and/or strenuous exercise per week.
| Meeting guidelines of 150 or more minute per week of strenuous or moderate exercise | ||||
|---|---|---|---|---|
| No ( | Yes ( | Total ( |
| |
| Age at diagnosis, years, | <.001[ | |||
| 18-39 | 81 (45.5%) | 97 (54.5%) | 178 (5.9%) | |
| 40-49 | 397 (53.4%) | 346 (46.6%) | 743 (24.8%) | |
| 50-59 | 501 (54.6%) | 417 (45.4%) | 918 (30.6%) | |
| 60-69 | 520 (64.4%) | 288 (35.6%) | 808 (26.9%) | |
| ≥70 | 273 (77.3%) | 80 (22.7%) | 353 (11.8%) | |
| Sex, | .455[ | |||
| Female | 1763 (59.0%) | 1224 (41.0%) | 2987 (99.6%) | |
| Male | 9 (69.2%) | 4 (30.8%) | 13 (0.4%) | |
| Race, | .335[ | |||
| African/African American/Black | 3 (30.0%) | 7 (70.0%) | 10 (0.3%) | |
| American Indian/Alaskan Native | 2 (50.0%) | 2 (50.0%) | 4 (0.1%) | |
| Asian | 16 (53.3%) | 14 (46.7%) | 30 (1.0%) | |
| Other | 11 (52.4%) | 10 (47.6%) | 21 (0.7%) | |
| Unknown/choose not to provide | 46 (53.5%) | 40 (46.5%) | 86 (2.9%) | |
| White | 1694 (59.5%) | 1155 (40.5%) | 2849 (95.0%) | |
| Ethnicity, | .330[ | |||
| Hispanic/Latino | 11 (78.6%) | 3 (21.4%) | 14 (0.5%) | |
| Not Hispanic/Latino | 1569 (59.0%) | 1092 (41.0%) | 2661 (88.7%) | |
| Unknown/choose not to provide | 192 (59.1%) | 133 (40.9%) | 325 (10.8%) | |
| Years between diagnosis and survey completion, | .020[ | |||
| <3 | 207 (56.7%) | 158 (43.3%) | 365 (12.2%) | |
| 3-4.9 | 222 (56.9%) | 168 (43.1%) | 390 (13.0%) | |
| 5-6.9 | 292 (57.1%) | 219 (42.9%) | 511 (17.1%) | |
| 7-8.9 | 324 (60.9%) | 208 (39.1%) | 532 (17.8%) | |
| 9-10.9 | 293 (59.7%) | 198 (40.3%) | 491 (16.4%) | |
| 11-12.9 | 219 (67.6%) | 105 (32.4%) | 324 (10.8%) | |
| 13+ | 211 (55.4%) | 170 (44.6%) | 381 (12.7%) | |
| Missing | 4 | 2 | 6 | |
| Recurrence, | .008[ | |||
| Did not recur | 1604 (58.3%) | 1145 (41.7%) | 2749 (92.0%) | |
| Recurred | 160 (67.2%) | 78 (32.8%) | 238 (8.0%) | |
| Missing | 8 | 5 | 13 | |
| Breast surgery, | <.001[ | |||
| Bilateral mastectomy | 486 (52.1%) | 447 (47.9%) | 933 (31.1%) | |
| Lumpectomy | 694 (61.0%) | 444 (39.0%) | 1138 (37.9%) | |
| None, biopsy only, other surgery, or unknown | 219 (66.8%) | 109 (33.2%) | 328 (10.9%) | |
| Unilateral mastectomy | 373 (62.1%) | 228 (37.9%) | 601 (20.0%) | |
| Radiation therapy, | .099[ | |||
| No radiation | 612 (57.0%) | 462 (43.0%) | 1074 (36.1%) | |
| Breast radiation | 1144 (60.1%) | 760 (39.9%) | 1904 (63.9%) | |
| Missing | 16 | 6 | 22 | |
| Hormonal therapy, | .911[ | |||
| Did not receive | 621 (58.8%) | 435 (41.2%) | 1056 (35.6%) | |
| Received | 1129 (59.0%) | 784 (41.0%) | 1913 (64.4%) | |
| Missing | 22 | 9 | 31 | |
| Chemotherapy, | .074[ | |||
| Did not receive | 1007 (60.2%) | 666 (39.8%) | 1673 (56.8%) | |
| Received | 724 (56.9%) | 548 (43.1%) | 1272 (43.2%) | |
| Missing | 41 | 14 | 55 | |
| Nodal status, | .568[ | |||
| N0/X/unknown | 1298 (58.8%) | 911 (41.2%) | 2209 (73.6%) | |
| N1-3 | 474 (59.9%) | 317 (40.1%) | 791 (26.4%) | |
| Metastasis status, | .030[ | |||
| M0/X/unknown | 1743 (58.8%) | 1219 (41.2%) | 2962 (98.7%) | |
| M1 | 29 (76.3%) | 9 (23.7%) | 38 (1.3%) | |
| Current body mass index, mean (SD) | 28.6 (6.4) | 25.9 (5.0) | 27.5 (6.0) | <.001[ |
Chi-square P-value.
Equal variance 2 sample t test;
Multivariate-adjusted associations of participant and tumor characteristics with likelihood of meeting guidelines of at least 150 minutes of moderate and/or strenuous exercise per week.
| Characteristic | Odds ratio (95% CI) |
|
|---|---|---|
| Age at diagnosis | <.001 | |
| 18-39 | 3.67 (2.34-5.73) | |
| 40-49 | 2.85 (2.06-3.93) | |
| 50-59 | 2.81 (2.06-3.83) | |
| 60-69 | 1.97 (1.45-2.69) | |
| ≥ 70 | 1.00 (ref) | |
| Years between diagnosis and survey completion | .007 | |
| <3 | 1.00 (ref) | |
| 3-4.9 | 1.00 (0.72-1.38) | |
| 5-6.9 | 0.85 (0.63-1.14) | |
| 7-8.9 | 0.76 (0.56-1.02) | |
| 9-10.9 | 0.76 (0.56-1.03) | |
| 11-12.9 | 0.55 (0.39-0.78) | |
| ≥ 13 | 0.93 (0.66-1.32) | |
| Recurrence | .04 | |
| Did not recur | 1.00 (ref) | |
| Recurred | 0.70 (0.50-0.98) | |
| Breast surgery | .03 | |
| Bilateral mastectomy | 1.00 (ref) | |
| Lumpectomy | 0.84 (0.66-1.08) | |
| None, biopsy only, other surgery or unknown | 0.75 (0.54-1.05) | |
| Unilateral mastectomy | 0.70 (0.56-0.89) | |
| Radiation therapy | .78 | |
| No radiation | 1.00 (ref) | |
| Breast radiation | 0.97 (0.76-1.21) | |
| Chemotherapy | .50 | |
| Did not receive | 1.00 (ref) | |
| Received | 0.93 (0.78-1.13) | |
| Metastasis status | .02 | |
| M0/X/unknown | 1.00 (ref) | |
| M1 | 0.32 (0.12-0.82) | |
| Current body mass index | 0.92 (0.90-0.93)[ | <.001 |
Logistic regression analysis, simultaneously modeling all variables found to be univariately significant with meeting guidelines (P < .10).
Decreased odds of meeting guidelines per one unit increase in BMI.